DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Cardiology Homepage

FDA gives nod to Stryker’s Neuroform Atlas Stent System Treats wide neck, intracranial, and saccular aneurysms

Neusoft's NueViz Prime 128-slice CT scores FDA clearance High-speed system may improve imaging in trauma, pediatrics and cardiac cases

Updated guidelines recommend use of S-ICDs for patients with ventricular arrhythmia Call to action for physicians

Konica Minolta signs group purchasing agreement with Premier for the Exa platform The three-year deal brings special pricing to 3,900 hospitals

A look at pheno-mapping in cardiovascular imaging Transforms data from cardiac imaging into an 'imaging phenotype'

Global interventional X-ray market to be worth over $3 billion in 2021 Low-volume facilities are purchasing new systems

Despite Brexit, ESC Congress will return to London in 2021 Decision based in large part on Mayor's active lifestyle initiative

In Mexico, a call for sterilized, used pacemakers as implants in new study An alternative for those who cannot afford new pacemakers

Image-guided Harpoon device safe and effective for mitral valve heart repair: study Less invasive than conventional mitral valve surgery

Global cardiac pacemaker market to almost double by 2023 As people live longer, cardiovascular disease becomes more prominent

Andrew Cleeland

Best Practices: Medical technology innovation must be at the heart of everything we do

By Andrew Cleeland
From the March 2017 issue of DOTmed HealthCare Business News magazine

A recent report from the Advanced Medical Technology Association (AdvaMed) sounded the alarm: The future of the American medical technology industry is at considerable risk. For more than two decades, our industry has been suffering from an ongoing, steady decline of entrepreneurship and venture capital funding, which has resulted in nearly a 60 percent drop in new med-tech startups. This statistic is particularly foreboding, when you consider that startups are typically the bedrock of innovation, developing breakthroughs that lead to significant health care cost reductions and more effective and efficient patient care.

Cardiovascular medicine, in particular, is a field that directly benefits from innovation due to its rapidly changing dynamics. Great strides were made in the 20th century in the efforts to manage cardiovascular disease, which directly improved morbidity and reduced mortality. Deaths from stroke have been cut by almost 60 percent and fatalities from heart disease have been cut by more than half.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



While these advancements are impressive, more needs to be done. Heart disease remains the leading cause of death and among one of the most expensive conditions to treat. As this field moves toward less invasive therapies and a stronger focus on prevention over treatment, we need to work together to ensure that we strengthen the innovation ecosystem to foster the cost-effective development of new technologies that benefit patients.

Early-stage startups, in particular, are the most fragile as they are burdened with an inordinate number of obstacles, which hinder the development of new ideas. In addition to challenges involving technology, market and fundraising competition, med-tech companies must also endure unpredictable regulatory agencies, nontransparent reimbursement decisions and a significantly more difficult fundraising environment.

To ensure that life-saving devices reach physicians, hospitals and ultimately the patients, we need to create an environment where early-stage startups are given the support to become self-sufficient. Here are four proven ways to do so:

Education and mentorship
Education and mentorship are two of the most valuable resources for entrepreneurs and vital to effectively bring medical devices into the global marketplace. Through the guidance of experienced physicians, young innovators can move faster and avoid many of the common pitfalls that frequently plague startups. Cardiovascular physicians are particularly well suited to provide guidance, given the range of clinical needs they are faced with on a daily basis and the field’s robust history of embracing medical innovation.
  Pages: 1 - 2 - 3 >>

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED